Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling

Edith Kario, Mina D. Marmor, Konstantin Adamsky, Ami Citri, Ido Amit, Ninette Amariglio, Gideon Rechavi, Yosef Yarden

Journal of Biological Chemistry · 2004 · 150 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

Suppressors of cytokine signaling (SOCS) are Src homology-2-containing proteins originally identified as negative regulators of cytokine signaling. Accumulating evidence indicates a role for SOCS proteins in the regulation of additional signaling pathways including receptor tyrosine kinases. Notably, SOCS36E, the Drosophila ortholog of mammalian SOCS5, was recently implicated as a negative regulator of the Drosophila ortholog of EGFR. In this study, we aimed at characterizing the role of SOCS5 in the negative regulation of EGFR. Here we show that the expression of SOCS5 and its closest homolog SOCS4 is elevated in cells following treatment with EGF, similar to several negative feedback regulators of EGFR whose expression is up-regulated upon receptor activation. The expression of SOCS5 led to a marked reduction in EGFR expression levels by promoting EGFR degradation. The reduction in EGFR levels and EGF-induced signaling in SOCS5-expressing cells requires both the Src homology-2 and SOCS box domains of SOCS5. Interestingly, EGFR is degraded by SOCS5 prior to EGF treatment in a ligand- and c-Cbl-independent manner. SOCS5 can associate with EGFR and can also bind the ElonginBC protein complex via its SOCS box, which may recruit an E3 ubiquitin ligase to promote EGFR degradation. Thus, we have characterized a novel function for SOCS5 in regulating EGFR and discuss its potential role in controlling EGFR homeostasis. Suppressors of cytokine signaling (SOCS) are Src homology-2-containing proteins originally identified as negative regulators of cytokine signaling. Accumulating evidence indicates a role for SOCS proteins in the regulation of additional signaling pathways including receptor tyrosine kinases. Notably, SOCS36E, the Drosophila ortholog of mammalian SOCS5, was recently implicated as a negative regulator of the Drosophila ortholog of EGFR. In this study, we aimed at characterizing the role of SOCS5 in the negative regulation of EGFR. Here we show that the expression of SOCS5 and its closest homolog SOCS4 is elevated in cells following treatment with EGF, similar to several negative feedback regulators of EGFR whose expression is up-regulated upon receptor activation. The expression of SOCS5 led to a marked reduction in EGFR expression levels by promoting EGFR degradation. The reduction in EGFR levels and EGF-induced signaling in SOCS5-expressing cells requires both the Src homology-2 and SOCS box domains of SOCS5. Interestingly, EGFR is degraded by SOCS5 prior to EGF treatment in a ligand- and c-Cbl-independent manner. SOCS5 can associate with EGFR and can also bind the ElonginBC protein complex via its SOCS box, which may recruit an E3 ubiquitin ligase to promote EGFR degradation. Thus, we have characterized a novel function for SOCS5 in regulating EGFR and discuss its potential role in controlling EGFR homeostasis. Signal transduction through receptor tyrosine kinases (RTKs) 1The abbreviations used are: RTK, receptor tyrosine kinase; CHO, Chinese hamster ovary; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; E1, ubiquitin-activating enzyme; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase; ERK, extracellular signal-regulated kinase; HEK, human embryonic kidney; DER, Drosophila EGFR; FGFR, fibroblast growth factor receptor; JAK, Janus kinase; NGFR, nerve growth factor receptor; GFP, green fluorescent protein; SOCS, suppressor of cytokine signaling; SB, SOCS box; SH2, Src homology 2; STAT, signal transducers and activator of transcription; mAb, monoclonal antibody. of the epidermal growth factor receptor (EGFR/ErbB) family occurs subsequent to binding of extracellular ligands and plays a critical role in the development and maintenance of adult tissues. A balance of both positive and negative signals is critical for proper cell function, and its deregulation is often implicated in the development of human diseases (1Dikic I. Giordano S. Curr. Opin. Cell Biol. 2003; 15: 128-135Crossref PubMed Scopus (287) Google Scholar). Removal of activated EGFR-ligand complexes from the cell surface by endocytosis and their subsequent degradation in the lysosome is the main process for the attenuation of signaling processes initiated by activated receptors (2Waterman H. Yarden Y. FEBS Lett. 2001; 490: 142-152Crossref PubMed Scopus (271) Google Scholar). ErbB receptors that show decreased down-regulation following ligand stimulation have been shown to possess increased and prolonged signaling capacity (3Waterman H. Katz M. Rubin C. Shtiegman K. Lavi S. Elson A. Jovin T. Yarden Y. EMBO J. 2002; 21: 303-313Crossref PubMed Scopus (227) Google Scholar, 4Wells A. Welsh J.B. Lazar C.S. Wiley H.S. Gill G.N. Rosenfeld M.G. Science. 1990; 247: 962-964Crossref PubMed Scopus (344) Google Scholar). A key component in the negative regulation of EGFR signaling is the E3 ubiquitin ligase c-Cbl. Following EGF stimulation, EGFR is phosphorylated and c-Cbl binds to a phosphorylated tyrosine residue of the receptor (5Levkowitz G. Waterman H. Ettenberg S.A. Katz M. Tsygankov A.Y. Alroy I. Lavi S. Iwai K. Reiss Y. Ciechanover A. Lipkowitz S. Yarden Y. Mol. Cell. 1999; 4: 1029-1040Abstract Full Text Full Text PDF PubMed Scopus (844) Google Scholar, M. T. A. M. H. A. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, S. H. S. A. PubMed Scopus Google Scholar). c-Cbl can also bind the receptor through the protein (3Waterman H. Katz M. Rubin C. Shtiegman K. Lavi S. Elson A. Jovin T. Yarden Y. EMBO J. 2002; 21: 303-313Crossref PubMed Scopus (227) Google Scholar). c-Cbl is phosphorylated as a can the of the EGFR and promote receptor degradation (5Levkowitz G. Waterman H. Ettenberg S.A. Katz M. Tsygankov A.Y. Alroy I. Lavi S. Iwai K. Reiss Y. Ciechanover A. Lipkowitz S. Yarden Y. Mol. Cell. 1999; 4: 1029-1040Abstract Full Text Full Text PDF PubMed Scopus (844) Google Scholar). c-Cbl can associate with and the receptor at the J. Biol. Full Text Full Text PDF PubMed Scopus Google c-Cbl with the EGFR the in prolonged of the receptor and its degradation G. J. H. J. J. Cell 2001; PubMed Google Scholar, G. Waterman H. S. Yarden Y. PubMed Scopus Google Scholar). of the EGFR is to as a signal for and that of ubiquitin to EGFR in and degradation of the protein K. S. S. I. I. Cell Biol. 2003; PubMed Scopus Google Scholar, Y. Shtiegman K. Katz M. Y. G. J. Yarden Y. J. Biol. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). In to proteins in the negative regulation of proteins are the of cytokine signaling a family of proteins identified as negative regulators of cytokine signaling. The SOCS family of proteins and the Src homology-2 SOCS proteins a an of and and a as the SOCS box in 2002; PubMed Scopus Google Scholar). In to the SOCS family of additional proteins have been identified that a and domains 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). SOCS proteins to signaling. can with for binding activated cytokine SOCS proteins can bind to their tyrosine SOCS proteins can their SOCS box to recruit an E3 ubiquitin ligase protein which proteins for degradation 2002; PubMed Scopus Google Scholar). following stimulation with can binding to phosphorylated tyrosine of activated to can recruit through the SOCS box and binds a protein that a A. G. M. S. A. 1999; PubMed Scopus Google Scholar). The ElonginBC complex with a family which binds to a T. A. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). the complex E3 ubiquitin ligase with the function by the SOCS protein and the E3 ubiquitin ligase by In the of the ubiquitin-activating and a the E3 complex can to its in degradation by the 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, I. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar). Accumulating evidence indicates a role for SOCS proteins in the regulation of signaling pathways cytokine a role for SOCS proteins in and EGFR signaling K. EMBO J. 2003; PubMed Scopus Google Scholar, J. S. Y. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, Cell Biol. 2001; PubMed Scopus Google Scholar, A. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). of SOCS including and is by EGF and is also phosphorylated following EGF treatment Cell Biol. 2001; PubMed Scopus Google Scholar, A. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). is for its with the and this the role of and of the and associate with EGFR and tyrosine A. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). signaling as the receptor proteins and the factor are also by SOCS family that the degradation of M. S. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, S. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). SOCS have also been identified in Drosophila as as in a a role for SOCS proteins in the regulation of signaling pathways cytokine signal transduction 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). of the Drosophila SOCS family SOCS36E, been implicated as a regulator of DER, the Drosophila EGFR is similar to mammalian SOCS5 in its and SOCS box its is and homology to SOCS The expression of in the Drosophila in in the adult that are with in EGFR signaling and are in for 2002; 21: PubMed Scopus Google Scholar). In an to the and regulation of EGFR was to whose expression is upon stimulation of cells with increased expression of several implicated in the regulation of EGFR as protein and the protein G. Rubin C. Katz M. I. A. J. G. H. Yarden Y. EMBO J. PubMed Scopus Google Scholar). In we of SOCS5 as as its closest upon treatment with EGF, which led to the role of SOCS proteins in the regulation of EGFR signaling. Here we show that SOCS5 to the degradation of EGFR in a ligand- and c-Cbl-independent manner. the and domains of SOCS5 are for EGFR degradation. we show in an and SOCS5 expression in the of EGFR to and in the attenuation of EGF-induced signaling. are in the of an the that from A of was from was from was by monoclonal was from Science. The for EGFR, and for have been (5Levkowitz G. Waterman H. Ettenberg S.A. Katz M. Tsygankov A.Y. Alroy I. Lavi S. Iwai K. Reiss Y. Ciechanover A. Lipkowitz S. Yarden Y. Mol. Cell. 1999; 4: 1029-1040Abstract Full Text Full Text PDF PubMed Scopus (844) Google Scholar, S. M. Yarden Y. S. A. 1999; PubMed Scopus Google Scholar). EGFR an was and for and and SOCS5 from for and fibroblast growth factor receptor from M. of and Cell and cells in with a and and cells in with a and for for and the for and The of in was with expression of SOCS5, cells the with with a cells in was to the cells for the for of SOCS5 and cells with and and a was to cell EGFR with to proteins and SOCS5 was with to protein The with and by and to a prior to was from from cells of of of of of and of and of to the by The following and of was the of the in and to and to as an for of the to in with and with a a to a the cells the cells for and with EGF for The was a was a and the to expression of cells and for in and with and a of The was with with and the cells at for prior to in Cell by and to by signal and cells in for in and in the cells in and a with a to a of expression EGFR, and the of EGFR (5Levkowitz G. Waterman H. Ettenberg S.A. Katz M. Tsygankov A.Y. Alroy I. Lavi S. Iwai K. Reiss Y. Ciechanover A. Lipkowitz S. Yarden Y. Mol. Cell. 1999; 4: 1029-1040Abstract Full Text Full Text PDF PubMed Scopus (844) Google Scholar). and a from SOCS5 expression and by the was by of from the The was with and and The following was from A. of was from was from M. was from was from S. Lipkowitz of and and from and The of SOCS5 by expression of negative regulators of signaling through is upon growth factor feedback aimed at regulation Cell 2003; PubMed Scopus Google Scholar). Notably, a by Cell Biol. 2001; PubMed Scopus Google that treatment of cells with growth as EGF and growth factor a in Thus, we the of EGF treatment the expression of SOCS family In a in which from cells was an in both and levels was following EGF and levels to levels expression in expression was for SOCS proteins in the and and the in the the expression of several SOCS family was also by The expression of and as as which was the was from cells an in the expression of following EGF The by is to the of as with the Interestingly, the expression of was also increased in a similar to that of the expression of was upon EGF treatment in the a was following of stimulation with of SOCS5 expression at the protein expression prior to EGF its expression increased following stimulation as the expression of the in that of EGFR in elevated expression of as as SOCS4 and SOCS5. SOCS5 the of SOCS proteins can the degradation of tyrosine kinases as and and as a signaling I. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar, K. EMBO J. 2003; PubMed Scopus Google Scholar, S. T. H. S. M. K. S. M. S. T. H. K. A. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). the shown in that the expression of several SOCS proteins is elevated following EGF stimulation, we proteins EGFR expression by of EGFR and SOCS which EGFR. Interestingly, EGFR levels in cells SOCS5 its closest of EGF treatment and the levels of SOCS5 expression of SOCS proteins including and EGFR expression EGF stimulation in the of Cell Biol. 2001; PubMed Scopus Google we the of SOCS family following EGF and tyrosine following EGF stimulation, tyrosine of SOCS4 was and Notably, the expression of SOCS4 SOCS5 to a reduction in EGFR expression levels SOCS5 the that down-regulation of EGFR requires EGF-induced of the SOCS the and domains are for degradation of cells with an an with a the cells for at with The cells and their to with the cells with a and the of and expression the cells for at with The cells and the to with the cells with a with of the SOCS5 the cells to for for and for at with EGF the cells and the to with the cells with a and with a a the cells for at with the cells and the to with the The of EGFR is the SOCS and of SOCS5 for the in EGFR with the of SOCS5 to EGFR its Drosophila SOCS36E, was recently implicated as a negative regulator of DER, the Drosophila EGFR 2002; 21: PubMed Scopus Google Scholar). we the regulation of EGFR. SOCS proteins their to recruit an E3 ubiquitin ligase complex and proteins 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, M. S. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, S. T. H. S. M. K. S. M. S. T. H. K. A. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google we the of SOCS5 is for the reduction in EGFR expression this we a of SOCS5, in which the was In to SOCS5, was to EGFR levels that the is for the in receptor In to the SB, SOCS proteins their for the of which to for protein degradation S. T. H. S. M. K. S. M. S. T. H. K. A. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). we the by a in which binding to T. J. Biol. Full Text PDF PubMed Google Scholar). and an of cells for In the expression of SOCS5 is the of an and can by Following of treatment with cells and EGFR was the of SOCS5 was following treatment with and its expression was by a marked reduction in the levels of EGFR expression was by treatment with EGFR levels that the of SOCS5, similar to SB, is for the in receptor SOCS5 the of ErbB Cell the of SOCS5 the levels of additional family and to and levels in cells SOCS5 levels by the expression of the receptors that to the ErbB family are also by SOCS5, we cells with with the a receptor tyrosine the nerve growth factor receptor The can with receptor tyrosine M. EMBO J. 1999; PubMed Scopus Google Scholar). levels by the expression of Thus, that SOCS5 can the expression of ErbB the expression of cell surface receptors as the EGFR in SOCS5-expressing EGFR levels are in SOCS5-expressing cells of receptor we a shown in the of EGFR was in cells SOCS5. EGFR was SOCS5 expression the the of EGFR to Interestingly, EGFR expression the of SOCS5 its from in cells to In cells with a the of SOCS5 was Thus, the in show that the reduction in EGFR levels in cells SOCS5 is to EGFR degradation that is by degradation of SOCS5 EGFR by SOCS5 of EGF stimulation, EGFR is degraded through a process its by c-Cbl (5Levkowitz G. Waterman H. Ettenberg S.A. Katz M. Tsygankov A.Y. Alroy I. Lavi S. Iwai K. Reiss Y. Ciechanover A. Lipkowitz S. Yarden Y. Mol. Cell. 1999; 4: 1029-1040Abstract Full Text Full Text PDF PubMed Scopus (844) Google Scholar, M. T. A. M. H. A. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). we the role of c-Cbl in the EGFR degradation we the of SOCS5 to the levels of the in which the c-Cbl binding tyrosine is (3Waterman H. Katz M. Rubin C. Shtiegman K. Lavi S. Elson A. Jovin T. Yarden Y. EMBO J. 2002; 21: 303-313Crossref PubMed Scopus (227) Google Scholar). The expression levels of and the and degradation and was EGFR (3Waterman H. Katz M. Rubin C. Shtiegman K. Lavi S. Elson A. Jovin T. Yarden Y. EMBO J. 2002; 21: 303-313Crossref PubMed Scopus (227) Google Scholar). the levels of and of SOCS5 the levels of both of receptors we cells with an with a of SOCS5 and is a with an ubiquitin ligase to a of to the EMBO J. PubMed Scopus Google Scholar). EGFR levels in SOCS5-expressing cells prior to EGF EGFR levels in cells c-Cbl subsequent to ligand stimulation in cells and In cells SOCS5 and EGFR levels to a similar as in cells with SOCS5 and an and Thus, the expression of with SOCS5 EGFR that SOCS5 an for EGFR degradation. that and degradation of EGFR are processes A and this we which EGFR degradation EGFR degradation. c-Cbl EGFR degradation upon EGF stimulation in both and cells Thus, c-Cbl and SOCS5 function to promote EGFR degradation. degradation of EGFR is by the expression of a SOCS5 and degradation of EGFR by the expression of the the SOCS5 with the degradation of the EGFR upon expression of SOCS5 may this EGFR was with SOCS5 in The cells with SOCS5 is a protein and of is for the of of SOCS5 for we that SOCS5 with EGFR as was in EGFR In that we also this with the SOCS5 and EGFR. In we also the of of the the domains of SOCS5 to bind the EGFR. The with EGFR, the with the receptor to that the of SOCS5 with EGFR is by the of SOCS5 with an additional role of the The SOCS of SOCS5 for EGFR and the of the ElonginBC that the of SOCS5 is for both with EGFR and for EGFR degradation and the of the of SOCS5 EGFR degradation the for the in EGFR we to of SOCS5 Thus, we the function of a of SOCS5 in which in critical and that the binding of to the M. S. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). SOCS5 can recruit the ElonginBC complex via the SOCS box SOCS5 proteins in cells with and to T. Science. PubMed Scopus Google expression levels are in cells In cells both and an of both proteins with SOCS5 The proteins with the SOCS5 that and of SOCS5 are for the binding of the ElonginBC that the SOCS5 bind we the of this EGFR. in which levels of EGFR, the of the of SOCS5 EGFR. and SOCS5 phosphorylated tyrosine following EGF EGFR levels decreased by SOCS5 and by the the SOCS5 Thus, to the SOCS5 the EGFR that the is for this degradation Notably, the of SOCS5 was for EGFR degradation following EGF stimulation, EGFR degradation EGF The complex by SOCS proteins is of and A. G. M. S. A. 1999; PubMed Scopus Google Scholar, T. A. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). this complex E3 ubiquitin ligase that the role of the is to of EGFR with the E3 ubiquitin ligase in EGFR degradation. we the EGFR in the of SOCS5 and an of the EGFR was in SOCS5-expressing cells with EGFR in in SOCS5-expressing degradation of EGFR its from the and of the G. J. H. J. J. Cell 2001; PubMed Google Scholar, G. Waterman H. S. Yarden Y. PubMed Scopus Google Scholar). we of SOCS5 EGFR degradation are also by this we used a fluorescent EGFR protein that of the of the receptor Jovin 1999; PubMed Scopus Google Scholar). cells with a protein and In was to the cell surface in cells SOCS5, was from the cell surface was in was by the expression of and at the cell surface with the of this to degradation of EGFR and and that EGFR and to the are in SOCS5-expressing and cells in with an of SOCS5 EGFR SOCS5 stimulation of cells with EGF is by of SOCS5 expression and subsequent degradation of EGFR we that signaling pathways activated by the EGFR also cells with a to a with an a Following EGF stimulation, is activated by by EGFR by Src kinases S. A. PubMed Scopus Google Scholar, I. K. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). in EGF stimulation led to a in was in both SOCS5 and cells The expression of which EGFR degradation in a in EGF-induced the of the SOCS5 EGF-induced activation. The expression of both of SOCS5 EGF-induced SOCS5 expression EGFR expression levels also EGF-induced in an and manner. The and of signaling through cell surface receptors are to the and subsequent receptor degradation the main process for attenuation of signaling initiated upon ligand binding to as EGFR with a key role by ubiquitin and the E3 ubiquitin ligase c-Cbl. signaling in the of the expression of additional which in the as and in Drosophila Cell Biol. 1999; PubMed Google Scholar). the proteins following EGF stimulation, we a from cells with that the levels of several SOCS family including are upon EGF treatment and the at both the and protein levels an we that the SOCS5 the degradation of EGFR in a manner. SOCS5 and its closest are the SOCS family that EGFR levels the of EGF to the expression and of several additional SOCS proteins and Cell Biol. 2001; PubMed Scopus Google Scholar, A. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). The expression of EGFR in SOCS5-expressing cells is the of degradation as by In to EGFR, SOCS5 also to the expression levels of and through similar the expression of the cell surface receptors and SOCS5 been shown to by S. A. PubMed Scopus Google and SOCS5 expression can and signaling Y. K. A. J. J. T. T. A. M. S. A. 2002; PubMed Scopus Google Scholar, A. M. EMBO J. 1999; PubMed Scopus Google Scholar). to ErbB and are with of SOCS36E, the Drosophila ortholog of mammalian SOCS5. DER, the Drosophila EGFR and the signaling by the of 2002; 21: PubMed Scopus Google Scholar). SOCS5 may of a negative feedback in which its expression is up-regulated upon EGF stimulation to EGF-induced signaling through receptor degradation. In several ErbB receptors to the protein signaling Y. PubMed Scopus Google Scholar, T. K. K. H. M. M. M. T. H. T. Y. T. I. Y. T. PubMed Scopus Google Scholar). Thus, both EGFR and the expression of SOCS5, which may signaling processes that are activated by the EGFR as of a cytokine and growth factor signaling SOCS5 recently C. Mol. Cell. Biol. PubMed Scopus Google and in the EGFR, of to processes are in In the for receptor we SOCS5 and similar to SOCS SOCS5 is phosphorylated by growth including EGF and and SOCS5 to for EGFR degradation its occurs subsequent to treatment with EGF, EGFR degradation is SOCS5 can associate with the protein that SOCS5 may also have additional in regulating signaling. In this is of to that tyrosine of by growth and for negative regulation of signaling for its with the which in promoting the of the Cell Biol. 2001; PubMed Scopus Google Scholar). the in show that and are also phosphorylated following EGF we that proteins may also in the regulation of EGFR signaling in a from regulation of receptor expression SOCS4 in EGFR levels similar to SOCS5, is phosphorylated upon treatment with EGF and may function EGFR degradation by SOCS5 requires both and domains and SOCS5 can bind both the EGFR and the ElonginBC complex The function of the SOCS5 is in the ElonginBC as the of critical for ElonginBC binding the of SOCS5 to EGFR degradation In the ElonginBC complex been shown to bind proteins and a which E3 ubiquitin ligase 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). Thus, the protein complex by the of SOCS5 may the in EGFR for degradation. In to EGFR this protein complex may for the degradation of SOCS5 SOCS proteins also shown to and to degradation by an E3 ubiquitin ligase complex A. G. M. S. A. 1999; PubMed Scopus Google Scholar). EGFR was upon of which may to degradation of receptors upon the complex by SOCS5 may EGFR degradation through additional its a which in proteins been shown to with the C. I. K. PubMed Scopus Google Scholar). The the for the of SOCS5 for EGFR degradation is EGFR is degraded prior to ligand stimulation, in which the receptor is to potential for proteins as SOCS5. that the of SOCS5 is for both its with the EGFR and EGFR degradation and and the tyrosine of the receptor is for the degradation process EGFR may by kinases as to a binding for the of SOCS5. a EGFR can phosphorylated by to for the domains of signaling as T. K. K. H. M. M. M. T. H. T. Y. T. I. Y. T. PubMed Scopus Google Scholar). that SOCS5 may signaling through EGFR by in to EGF as SOCS5 may bind EGFR through with a protein that binds EGFR. EGF-induced degradation of EGFR of the receptor by c-Cbl. EGFR degradation upon of SOCS5 is both and c-Cbl EGF-induced endocytosis the of EGFR from the cell surface and to a G. J. H. J. J. Cell 2001; PubMed Google Scholar, G. Waterman H. S. Yarden Y. PubMed Scopus Google Scholar). The of this show in SOCS5-expressing EGFR is in The of the in which the receptor is in SOCS5-expressing cells to characterized and may similar to the endocytosis an as The of SOCS5 with EGFR in this to in SOCS5 by of its and we show that signaling was also by SOCS5 expression of was in SOCS5-expressing cells and EGF-induced was by the expression of both the and of SOCS5, that domains are for the regulation of EGFR. The in signaling may to the reduction in levels of the In the of EGFR in SOCS5-expressing cells may in the receptor for EGF The in which EGFR is degraded in SOCS5-expressing cells is to characterized for degradation are proteins as and I. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar, S. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). of proteins is by the and treatment of cells with degradation of and In to cell surface receptors as EGFR are from the cell surface and through an in degradation Yarden Y. PubMed Scopus Google Scholar). evidence a role for in the EGFR degradation J. Cell Biol. 2002; PubMed Scopus Google that treatment of cells with lysosome EGFR degradation the of receptor In cells with EGFR was to the of the and its to was In J. A. A. J. Biol. Full Text Full Text PDF PubMed Scopus Google an a key protein in the regulation of from to and the in and the of the of EGFR. Thus, is evidence for a the and the The of this that EGFR degradation by SOCS5 can by treatment with a as this that SOCS5 the for EGFR degradation. Interestingly, the E3 ubiquitin ligase complex that is to the complex by SOCS proteins been shown to both and degradation as by EMBO J. 2003; PubMed Scopus Google that the receptor degradation in the In we the following the role of SOCS5 in the regulation of EGFR. Following stimulation of cells by growth SOCS5 expression is SOCS5 can binding to the EGFR, via a tyrosine residue phosphorylated by a tyrosine via a phosphorylated SOCS5 can recruit the ElonginBC complex to the receptor to EGFR degradation. EGFR degradation is by its from the cell ligand binding and EGF-induced signaling. The of the proteins in the degradation process to characterized and may proteins SOCS5 and the EGFR as as proteins with SOCS5 and the ElonginBC as the and the of EGFR degradation to T. A. M. S. T. A. and for and C. Rubin and K. Shtiegman for and critical of the

References

40